Navigation Links
PharmAthene Enhances Executive Leadership Team and Appoints Joan Fusco, Ph.D. Senior Vice President of Operations
Date:2/8/2008

ANNAPOLIS, Md., Feb. 8 /PRNewswire-FirstCall/ -- PharmAthene, Inc., a biodefense company developing medical countermeasures against biological and chemical threats, announced today that it has appointed Joan Fusco, Ph.D. Senior Vice President of Operations.

Dr. Fusco brings more than twenty years of experience in the biotechnology and vaccines industry, with broad experience in a variety of functional areas including, R&D, pilot plant operations, regulatory affairs, clinical development and commercial manufacturing within both large and small biopharmaceutical companies. Prior to joining PharmAthene, Dr. Fusco served as Senior Vice President, Operations for Acambis, Inc., where she had been responsible for overall operations of the company, including development, manufacturing, quality systems, project management, IT and logistics/purchasing. While at Acambis, Dr. Fusco oversaw the development and manufacturing operations of the company's biodefense and portfolio programs, and was responsible for ensuring delivery of a newly-licensed biodefense vaccine. Prior thereto, Dr. Fusco served as Vice President, Technical Affairs - Vaccines, and Vice President, Global Project Management for Baxter Healthcare Corporation, BioScience Division, where she held project management responsibility for the vaccines development pipeline and successfully shepherded two new vaccines from discovery through to commercialization.

David P. Wright, President and Chief Executive Officer, commented, "Joan's considerable experience in biodefense product development and commercialization is a tremendous asset to PharmAthene. We're very pleased to welcome her to our senior management team and are confident that her expertise in all facets of biopharmaceutical product development will help to ensure the success of Valortim (TM) and Protexia(R), our biodefense product candidates intended for the treatment of anthrax and chemical nerve agents, respectively."

Mr. Wright co
'/>"/>

SOURCE PharmAthene, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related biology technology :

1. Hearing Scheduled in the Delaware Court of Chancery for August 27, 2007 to Establish the Valid Approval and Consummation of the Merger Between PharmAthene, Inc. and Healthcare Acquisition Corp.
2. Proceedings to Affirm Merger Between PharmAthene and Healthcare Acquisition Corp Initiated in Delaware Chancery Court
3. PharmAthene Named as Contractor in $13.9 Million Award Notice Published by the Department of Health and Human Services
4. Delaware Court Denies Motion by SIGA Technologies Seeking to Dismiss PharmAthenes Legal Action in Breach of Contract Lawsuit Against SIGA
5. PharmAthene to Present at the BIO CEO & Investor Conference 2008
6. ScienceDirect Maximizes Research Capabilities, Enhances the Research Process
7. Thermo Fisher Scientific Executive Officers Adopting SEC Rule 10b5-1 Trading Programs
8. Todd R. Nelson Named Chief Executive Officer of eBioscience, Inc.
9. Anadys Pharmaceuticals Appoints Steve Worland, Ph.D. as President and Chief Executive Officer
10. Prestwick Pharmaceuticals, Inc. Continues to Build Management Team With Appointment of Martin Stogniew, Ph.D. as Executive Vice President, Chief Technology Officer
11. NanoSensors, Inc. Announces Reorganization of Executive Management Team and Redirection of Operations

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/24/2009)...K,Iceland,November24/PRNewswire-FirstCall/--deCODE...ovalofallofits,"firstday"motionsbytheU.S.Bankruptc...t").deCODElastweekfiledavoluntarypetitionfor,relie...the,BankruptcyCourt. , TheordersissuedbytheBa...sbusinessduringtheChapter11proceedings.Inparticula...
(Date:11/24/2009)... The FBI recently approved the Promega Po...cipating in or generating DNA records for the Nati...Madison, WI USA (PRWEB) -- The FBI recently approv...se by laboratories participating in, or generating...DIS). NDIS currently contains more than seven mill...
(Date:11/24/2009)...ITY,Calif.,Nov.24/PRNewswire-FirstCall/--GenomicHe...tt,GenomicHealth,sExecutiveChairman,willpresentatt...orkCityonTuesday,December1,2009at10:00a.m.ET. ,...hepresentation,visittheInvestorRelationssectionofG...lth.com .Pleaseconnecttothewebsiteatleast15minutes...
(Date:11/23/2009)...Y, Nov. 23, 2009 In a provocative new study, a Un...on dioxide emissions the major cause of global wa...nomy collapses or society builds the equivalent of...oks unlikely that there will be any substantial ne...ion in carbon dioxide emission rates," says the ne...
Breaking Biology Technology:deCODE genetics, Inc. Announces Approval of First Day Motions by Bankruptcy Court 2deCODE genetics, Inc. Announces Approval of First Day Motions by Bankruptcy Court 3NDIS Approval of Promega PowerPlex Kit Clears Path for More DNA Profiles to be Added to U.S. Database 2Genomic Health to Present at Piper Jaffray Health Care Conference 2Is global warming unstoppable? 2Is global warming unstoppable? 3Is global warming unstoppable? 4
... long,been known for its amber waves of grain and ...lized, however, is that Kansas, agricultural,exper...ar beyond the farm,-- namely, the scientific labor...gths in agribusiness and the,animal-health industr...ont,of some of the most innovative and important a...
...dustrys rallying cry of smaller and faster, the ne...re likely to come from microchips and data storage...ganic molecules and polymers. With innovative meas...lecules, NIST researchers reported at the March Me...ve improved manipulation of so-called block copoly...
...genetics,(Nasdaq: DCGN ) today announced its cons...r ended December 31, 2007. A conference call to di...will be webcast live tomorrow,Thursday, March 13, ...oss for the year ended December 31, 2007 was $95.5...ar 2006. Basic and diluted net,loss per share was ...
Other Biology Technology:Op-Ed: The NBAF Would Build on Kansas' Existing Strengths in Bioscience 2Copolymers block out new approaches to microelectronics at NIST 2deCODE Genetics Announces Full-year 2007 Financial Results 2deCODE Genetics Announces Full-year 2007 Financial Results 3deCODE Genetics Announces Full-year 2007 Financial Results 4deCODE Genetics Announces Full-year 2007 Financial Results 5deCODE Genetics Announces Full-year 2007 Financial Results 6deCODE Genetics Announces Full-year 2007 Financial Results 7deCODE Genetics Announces Full-year 2007 Financial Results 8deCODE Genetics Announces Full-year 2007 Financial Results 9
(Date:11/26/2009)... Prized for their impressive antlers, red deer ha...ons. But a deer,s antlers are much more than decor...gether when duelling. John Currey, from The Univer...ical properties of bone for over half a century an...es of antler through a long-standing collaboration...
(Date:11/26/2009)... A survey carried out in eight European countries... infectious disease pandemic could have a signific...hers writing in the open access journal BMC Infec...on on school days and weekends/holidays, finding t...iel Hens, from Hasselt and Antwerp University, Bel...
(Date:11/26/2009)... , Heidelberg, 27 November 2009 What are the b...nts required to produce a cell that can survive on... a cell, and understand how an entire organism fun...stions that scientists in a partnership between th...Heidelberg, Germany, and the Centre de Regulacio G...
Breaking Biology News(10 mins):Tough yet stiff deer antler is materials scientist's dream 2School closure could reduce swine flu transmission by 21 percent 2First-ever blueprint of a minimal cell is more complex than expected 2First-ever blueprint of a minimal cell is more complex than expected 3Results From Phase 1 Clinical Study of PEG PAL in PKU and Update on Phase 2 Clinical Study 48293 1Results From Phase 1 Clinical Study of PEG PAL in PKU and Update on Phase 2 Clinical Study 48293 2Results From Phase 1 Clinical Study of PEG PAL in PKU and Update on Phase 2 Clinical Study 48293 3Results From Phase 1 Clinical Study of PEG PAL in PKU and Update on Phase 2 Clinical Study 48293 4Industry Recognized and Trusted Leader Bruce Matter Joins Healthcare IT Company Peminic Inc as Company Growth in the Areas of Patient Safety Ris 48289 1Industry Recognized and Trusted Leader Bruce Matter Joins Healthcare IT Company Peminic Inc as Company Growth in the Areas of Patient Safety Ris 48289 2Arete Therapeutics Presents Positive Clinical and Preclinical Data for AR9281 48285 1Arete Therapeutics Presents Positive Clinical and Preclinical Data for AR9281 48285 2Arete Therapeutics Presents Positive Clinical and Preclinical Data for AR9281 48285 3Arete Therapeutics Presents Positive Clinical and Preclinical Data for AR9281 48285 4
...combating AIDS in Russia may be to treat HIV-infe... of HIV in Russia suggests that treating injectio...slow transmission of the virus among the general ...December issue of the journal AIDS, was led by Do...airs Palo Alto Health Care System and professor of...
... of two proteins in the blood of pregnant women ap...eclampsia, a life-threatening complication of preg...nal Institutes of Health and Beth Israel Deaconess...th the growth and function of blood vessels, also ...ng pregnancy. , The findings appear in the Septem...
...s use their whiskers to explore their environment ...r world. Rodents, for example, use their whiskers ...s, and seals use their whiskers to track the fluid...ty engineers have been studying the whisker system...mation from the whiskers gets transmitted to the b...
Other Biology News:To slow AIDS in Russia, treat HIV-positive addicts, Stanford study says 2To slow AIDS in Russia, treat HIV-positive addicts, Stanford study says 3Molecules in blood foretell development of preeclampsia 2Molecules in blood foretell development of preeclampsia 3Molecules in blood foretell development of preeclampsia 4Robotic whiskers can sense three-dimensional environment 2
Peroxidase, Horseradish, Conjugate-Stabilizing Solution from Calbiochem
...cells-directed transfection reagent : jetPEI-RGD i...allows targeted efficient transfection of integrin...grins are adhesion molecules involved in cell-cell...s, including a51 and most aV-containing proteins, ...
GIBCO Dulbeccos Modified Eagle Medium (D-MEM); powder (high glucose) from Invitrogen
MacMelt Software, Mac from Bio-Rad
Biology Products: